alexa Usage of Rotarix® in Neonatal Units across the United
ISSN: 2157-7560

Journal of Vaccines & Vaccination
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Short Communication

Usage of Rotarix® in Neonatal Units across the United Kingdom

Hussain Alsaffar1, Katherine Woodger1 and Ignatius Losa2*
1Hussain Alsaffar, Department of Paediatrics and Neonatology, Warrington District General Hospital, Lovely Lane, Warrington, Cheshire, WA5 1QG, UK
2Consultant Paediatrician and Immunisation Adviser, Department of Paediatrics, Macclesfield District General Hospital, Macclesfield, SK10 3BL, UK
Corresponding Author : Ignatius Losa
East Cheshire nhs Trust
Macclesfield, Cheshire, UK
Tel: 01625 421000
E-mail: [email protected]
Received May 26 2014; Accepted June 30 2014; Published July 04 2014
Citation: Alsaffar H, Woodger K, Los I (2014) Usage of Rotarix® in Neonatal Units across the United Kingdom. J Vaccines Vaccin 5:240. doi:10.4172/2157-7560.1000240
Copyright: © 2014 Alsaffar H, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
 

Abstract

Following advice and recommendations by the Joint Committee on Vaccination and Immunisation (JCVI), and in line with standing commitments on patient rights under the NHS constitution on implementing such recommendations, a series of changes to England’s national immunisation programme took place from July 2013 including the introduction of Rotavirus vaccine (Rotarix® by GlaxoSmithKline Biologicals s.a.) into the routine childhood UK schedule for babies from 2 months of age [1].

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords